Ethan Siev, MD

Cardiology, Cardiovascular Disease
Primary Office
Address 1150 N 35th Avenue
Suite 600
Hollywood, FL 33021

About Me

Ethan Siev, MD, is board certified in internal medicine and fellowship trained in cardiovascular disease. He earned his medical degree in 1984 from Albert Einstein College of Medicine, Yeshiva College, in Bronx, New York. Dr. Siev then completed an internship in internal medicine at St. Luke’s-Roosevelt Hospital Center in New York, where he also completed his residency in internal medicine. Dr. Siev continued his medical training with a fellowship in cardiovascular disease from North Shore University, Cornell Medical Center, Manhasset, New York.

After serving as an emergency medicine physician at St. Luke’s Hospital, a Level I trauma center in New York, Dr. Siev joined Cardiovascular Consultants of South Florida. He served as chief of the Division of Cardiology at Memorial Healthcare System from 1994 to 1998. Dr. Siev also taught clinical courses at the medical school at Nova Southeastern University from 1995 to 2003. He served as president of Memorial EKG Associates since 2000. In 2016, Dr. Siev joined Memorial Physician Group and Memorial Cardiac and Vascular Institute as a cardiologist.

Related Medical Services

Meet Dr. Siev


  • Albert Einstein College Of Medicine, 1984
  • St Luke's Roosevelt Hospital, 1987, Internal Medicine
  • North Shore University Hospital, 1989, Cardiovascular Disease
American Board of Internal Medicine-Cardiovascular Disease
American Board of Internal Medicine-Internal Medicine
  • Hebrew


Professional Organizations

  • American College of Cardiology
  • American Society of Echocardiography
  • Broward County Medical Association
  • Florida Medical Association


  • Odyssey Outcomes: PCSK9 receptor inhibitors in ACS patients with persistently elevated lipid levels despite high dose statins
  • Carmelina: Type II diabetics with high cardiac and renal risks treated with Tradjenta
  • Warfarin genetic testing for dose ranging trial
  • Trilogy ACS: Comparison of Prasugrel vs. Clopidegrel in medically managed ACS patients
  • RELY trial: Dabigatran vs. Warfarin in stroke prevention in patients with chronic atrial fibrillation
  • Coral Trial: Management of Accelerated Hypertension due to renal artery stenosis with renal artery stenting vs. medical therapy
  • African-American Heart Failure trial (AAHeFT): ACE inhibitor vs. nitrates and hydralazine in African Americans with heart failure
  • SCD-HFT: NIH study randomizing Class III and IV CHF patients to standard medical therapy vs. amiodarone vs. ICD
  • Cariporide trial: Randomized placebo controlled trial of cariporide in minimizing reperfusion injury in ACS

Related Physicians